Perioperative bridging with fondaparinux in a woman with antithrombin deficiency

[1] Fixed dosage of low-molecular-weight heparins causes large individual variation in coagulability, only partly correlated to body weight [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (01) : 83 - 89

[2] ANSELL J, 2005, CHEST, V127, P415

[3] Fondaparinux: a new synthetic and selective inhibitor of Factor Xa [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2004, 17 (01) : 89 - 104

[4] Béguin S, 1999, HAEMOSTASIS, V29, P170

[5] The pharmacokinetics of fondaparinux sodium in healthy volunteers [J]. CLINICAL PHARMACOKINETICS, 2002, 41 (Suppl 2) : 1 - 9

[6] Heparin and low-molecular-weight heparin - The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy [J]. CHEST, 2004, 126 (03) : 188S - 203S

[7] Heparin resistance and antithrombin: Should it still be called heparin resistance? [J]. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2004, 18 (02) : 129 - 130

[8] OLSON ST, 1992, J BIOL CHEM, V267, P12528

[9] Fondaparinux sodium mechanism of action -: Identification of specific binding to purified and human plasma-derived proteins [J]. CLINICAL PHARMACOKINETICS, 2002, 41 (Suppl 2) : 11 - 18

[10] Spyropoulos AC, 2005, CURR OPIN PULM MED, V11, P373

[1] Fixed dosage of low-molecular-weight heparins causes large individual variation in coagulability, only partly correlated to body weight [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (01) : 83 - 89

[2] ANSELL J, 2005, CHEST, V127, P415

[3] Fondaparinux: a new synthetic and selective inhibitor of Factor Xa [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2004, 17 (01) : 89 - 104

[4] Béguin S, 1999, HAEMOSTASIS, V29, P170

[5] The pharmacokinetics of fondaparinux sodium in healthy volunteers [J]. CLINICAL PHARMACOKINETICS, 2002, 41 (Suppl 2) : 1 - 9

[6] Heparin and low-molecular-weight heparin - The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy [J]. CHEST, 2004, 126 (03) : 188S - 203S

[7] Heparin resistance and antithrombin: Should it still be called heparin resistance? [J]. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2004, 18 (02) : 129 - 130

[8] OLSON ST, 1992, J BIOL CHEM, V267, P12528

[9] Fondaparinux sodium mechanism of action -: Identification of specific binding to purified and human plasma-derived proteins [J]. CLINICAL PHARMACOKINETICS, 2002, 41 (Suppl 2) : 11 - 18

[10] Spyropoulos AC, 2005, CURR OPIN PULM MED, V11, P373